Payment by PayID or bank transfer.
A Certificate of Analysis is not currently linked for this product.
Published research is separate from the batch test results for this vial.
Browse the research libraryFour-peptide regenerative research blend: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg (80mg total per vial). Studied across collagen synthesis, tissue-repair, angiogenesis and anti-inflammatory models.
Listed Purity
99.00%
Method
HPLC
Certificate
Not published$2.50 / mg
In stock, ships from Sydney
Low stock, selling fast. Once we sell out, new orders reserve a slot in the next batch (Approximately 2 weeks).
For research use only. Not for human consumption. By purchasing this product, you confirm it will be used solely for legitimate research purposes.
Four-peptide regenerative research blend: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg (80mg total per vial). Studied across collagen synthesis, tissue-repair, angiogenesis and anti-inflammatory models.
KLOW is a combination research blend of four peptides studied for overlapping regenerative and cytoprotective pathways: GHK-Cu (50mg), the copper tripeptide associated in published work with collagen and elastin synthesis, antioxidant activity and broad gene-expression modulation; BPC-157 (10mg), a gastric pentadecapeptide investigated for angiogenesis and tendon, ligament and gut-lining repair in animal models; TB-500 (10mg), a thymosin β-4 fragment studied for actin-cytoskeleton regulation and cell migration in tissue-repair research; and KPV (10mg), the C-terminal α-MSH tripeptide associated with NF-κB pathway inhibition and reduced inflammatory cytokine secretion. The blend is supplied lyophilised, 80mg total per vial. For research use only. Not for human consumption.
